Ovarian cancer risk prediction study with genetic testing
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at whether certain genetic mutations can help predict the risk of getting ovarian cancer. It aims to better understand how these inherited changes lead to the disease, which could help with early detection and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have epithelial ovarian cancer (the most common type).
- You are 18 years old or older.
- Your cancer diagnosis has been confirmed by a pathology report.
- You have had a genetic test that found a harmful inherited mutation (a change in a gene that increases cancer risk).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study looks for early signs of ovarian cancer in a simple blood test. It may help people with BRCA gene changes catch problems sooner, before or after preventive surgery.
This study looks at family members of people with ovarian cancer to build a better tool for predicting their risk. If you have a BRCA1 or BRCA2 gene mutation, you may be able to join.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study looks at whether a score based on your genes can predict the risk of epithelial ovarian cancer. It compares women newly diagnosed with this cancer to women who have never had it.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.